Khan, Poulami <br/><br/>
Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration.  [electronic resource] 

 -  Scientific reports  11 2019 
 - 16913 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-019-53134-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Aspirin--pharmacology<br/>Carcinoma, Non-Small-Cell Lung<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Humans<br/>Lung Neoplasms<br/>Neoplastic Stem Cells--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism<br/>Transcription Factor RelA--metabolism<br/>p300-CBP Transcription Factors--metabolism